EBOS petcare bid falls over

Lack of enthusiasm from investors pegged as major factor in distributor withdrawing from Greencross purchase The anticipated $3.75 billion deal which would have seen pharmaceutical distributor EBOS buy up the pet company Greencross has stopped in its tracks after weak interest from investors. EBOS sent out a statement on Wednesday 22 November (2023) confirming that